Human Bird Flu Cases Spur Retail Trader Rush Into Vaccine Stocks

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 50%

Business News News

Business Business Latest News,Business Business Headlines

Mounting cases of bird flu in humans is luring the day trading crowd to snap up stock in vaccine developers. It’s a familiar setup for industry veterans who have witnessed past trading frenzies at the first signs of an outbreak.

Adnoc to Sell 5.

7 Billion in Spain in Global AWS BuildoutSecond Human Bird Flu Infection in US Reported in MichiganUkraine Accuses Former Zelenskiy Aide of Illicit EnrichmentCredit concerns persist as banks gear up to report second-quarter resultsA Hot Button Issue for SEC Threatens to Erode Ether-ETF DemandLos Angeles Was Only Big US County to See Jobs Drop in 2023Calpers Veteran Who Oversees Private Debt Bets to Leave in JulyThe 15 Minutes on a Citi Trading Desk That Sparked a Flash CrashUkraine Accuses...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 83. in BUSİNESS

Business Business Latest News, Business Business Headlines